Clinical Trial Update: Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006) [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating Cadonilimab in combination with chemoradiotherapy for esophageal cancer (EC-CRT-006). The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophagus Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING